Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8284)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 15, 2022 (publication date) through Jul 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Singh AK, Singh R. Renin-angiotensin system blockers-SGLT2 inhibitors-mineralocorticoid receptor antagonists in diabetic kidney disease: A tale of the past two decades! World J Diabetes 2022; 13(7): 471-481 [PMID: 36051422 DOI: 10.4239/wjd.v13.i7.471] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v13/i7/471.htm |
| Number | Citing Articles |
| 1 |
Paola Romagnani, Rajiv Agarwal, Juliana C. N. Chan, Adeera Levin, Robert Kalyesubula, Sabine Karam, Masaomi Nangaku, Bernardo Rodríguez-Iturbe, Hans-Joachim Anders. Chronic kidney disease. Nature Reviews Disease Primers 2025; 11(1) doi: 10.1038/s41572-024-00589-9
|
| 2 |
Adlyne Reena Asirvatham, Arthur Joseph Asirvatham, Shriraam Mahadevan. SGLT2 Inhibitors and Finerenone: A friendly Duo in the Treatment of Diabetic Kidney Disease?. Journal of The Association of Physicians of India 2024; 72(12): e35 doi: 10.59556/japi.72.0759
|
| 3 |
Alberto Ortiz, Roberto Alcázar Arroyo, Pedro Pablo Casado Escribano, Beatriz Fernández-Fernández, Francisco Martínez Debén, Juan Diego Mediavilla, Alfredo Michan-Doña, Maria Jose Soler, Jose Luis Gorriz. Optimization of potassium management in patients with chronic kidney disease and type 2 diabetes on finerenone. Expert Review of Clinical Pharmacology 2023; 16(6): 519 doi: 10.1080/17512433.2023.2213888
|
| 4 |
Chengren Xu, Xiaowen Ha, Shufen Yang, Xuefei Tian, Hong Jiang. Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1232790
|
| 5 |
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, Anoop Misra. Finerenone in diabetic kidney disease: A systematic review and critical appraisal. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2022; 16(10): 102638 doi: 10.1016/j.dsx.2022.102638
|